Retinoblastoma is a highly malignant neoplasm. Most of the cases are usually far advanced at the time of detection, requiring enucleation to salvage the child's life. However, the cosmetic rehabilitation of these patients should always be an integral part of their treatment, which helps in their re-integration in the society. This paper presents a case of 5-year-old patient who had undergone enucleation of her left eye due to retinoblastoma. A multidisciplinary approach, including ophthalmologist, psychotherapist, and a prosthodontist, was adopted to meet her physical, psychological, functional, emotional, social, and cosmetic demands. The patient was rehabilitated cosmetically with precisely fabricated ocular prosthesis. An ocular prosthesis is a highly positive and non-invasive approach to improve the cosmetic appearance and psychological well-being of patient.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680843 | PMC |
http://dx.doi.org/10.4103/0973-1075.110241 | DOI Listing |
Comput Methods Biomech Biomed Engin
January 2025
School of Computer Science and Artificial Intelligence, Aliyun School of Big Data, Changzhou University, Changzhou, P.R. China.
Slow eye movements (SEMs) are a reliable physiological marker of drivers' sleep onset, often accompanied by EEG alpha wave attenuation. A parallel multimodal 1D convolutional neural network (PM-1D-CNN) model is proposed to classify SEMs. The model uses two parallel 1D-CNN blocks to extract features from EOG and EEG signals, which are then fused and fed into fully connected layers for classification.
View Article and Find Full Text PDFGynecol Oncol Rep
February 2025
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, United States.
Introduction: To report a series of patients who developed ocular surface disease related to tisotumab vedotin-tftv (TV), an antibody-drug conjugate (ADC) approved for the treatment of recurrent or metastatic cervical cancer.
Methods: This was a multicenter retrospective chart review study of patients who developed ocular surface disease related to TV between April 1st, 2022 to August 31st, 2023.
Results: Five patients were identified who developed ocular surface disease while on TV.
Ophthalmol Sci
November 2024
Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Purpose: The aim is to assess GPT-4V's (OpenAI) diagnostic accuracy and its capability to identify glaucoma-related features compared to expert evaluations.
Design: Evaluation of multimodal large language models for reviewing fundus images in glaucoma.
Subjects: A total of 300 fundus images from 3 public datasets (ACRIMA, ORIGA, and RIM-One v3) that included 139 glaucomatous and 161 nonglaucomatous cases were analyzed.
Cureus
January 2025
Emergency Medicine Department, Maidstone and Tunbridge Wells NHS Trust, Maidstone, GBR.
Visual impairment and eye disease remain a significant burden, highlighting the need for further support regarding eye care services. Artificial intelligence (AI) and its rapid advancements are providing an avenue for transforming healthcare. As a result, this provides a potential avenue to address the growing challenges with eye health and could assist in settings such as eye casualty departments.
View Article and Find Full Text PDFBMC Cancer
January 2025
Department of Plastic Surgery, University of California, Irvine, CA, USA.
Background: While prosthesis-associated malignancies have been acknowledged, awareness among surgeons and patients in the ophthalmologic field remains limited, despite the frequent occurrence of prosthesis-related surgeries. We aim to address this gap through a scoping review of malignancies following ophthalmologic surgeries involving various foreign device/prosthesis/implants.
Methods: Following PRISMA guidelines, we conducted a review using PubMed and Embase for studies on cancer and ophthalmic prostheses/implants.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!